Indole-3-carboxaldehyde, an important byproduct of tryptophan metabolism, may be downregulated due to insufficient IDO pathway activation or gut microbiota dysregulation, and it can promote tumor immunotherapy [38]. The gene discussed is IDO1; the disease is neoplasm.